These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 3398694)

  • 1. Silymarin improves metabolism and disposition of aspirin in cirrhotic rats.
    Mourelle M; Favari L
    Life Sci; 1988; 43(3):201-7. PubMed ID: 3398694
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heterogeneity of changes on the disposition of aspirin in rats with CCl4-induced chronic liver damage.
    Mourelle M; Amezcua JL; Favari L
    Biochem Pharmacol; 1987 Sep; 36(18):3021-5. PubMed ID: 3115269
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aspirin disposition in rats acutely intoxicated with CCl4.
    Favari L; Mourelle M; Amezcua JL
    J Appl Toxicol; 1987 Dec; 7(6):361-5. PubMed ID: 3429760
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of CCL4-induced liver cirrhosis by silymarin.
    Mourelle M; Muriel P; Favari L; Franco T
    Fundam Clin Pharmacol; 1989; 3(3):183-91. PubMed ID: 2548940
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative effects of colchicine and silymarin on CCl4-chronic liver damage in rats.
    Favari L; Pérez-Alvarez V
    Arch Med Res; 1997; 28(1):11-7. PubMed ID: 9078581
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of membrane composition in ATPase activities of cirrhotic rat liver: effect of silymarin.
    Muriel P; Mourelle M
    J Appl Toxicol; 1990 Aug; 10(4):281-4. PubMed ID: 2167906
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of portal vein ligation and silymarin treatment on aspirin metabolism and disposition in rats.
    Favari L; Soto C; Mourelle M
    Biopharm Drug Dispos; 1997 Jan; 18(1):53-64. PubMed ID: 9008269
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Erythrocyte defects precede the onset of CCl4-induced liver cirrhosis. Protection by silymarin.
    Mourelle M; Franco MT
    Life Sci; 1991; 48(11):1083-90. PubMed ID: 1847733
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention by silymarin of membrane alterations in acute CCl4 liver damage.
    Muriel P; Mourelle M
    J Appl Toxicol; 1990 Aug; 10(4):275-9. PubMed ID: 1975258
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of biphenyldimethyl-dicarboxylate administration alone or combined with silymarin in the CCL4 model of liver fibrosis in rats.
    Abdel-Salam OM; Sleem AA; Morsy FA
    ScientificWorldJournal; 2007 Aug; 7():1242-55. PubMed ID: 17721639
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of silymarin on the resolution of liver fibrosis induced by carbon tetrachloride in rats.
    Tsai JH; Liu JY; Wu TT; Ho PC; Huang CY; Shyu JC; Hsieh YS; Tsai CC; Liu YC
    J Viral Hepat; 2008 Jul; 15(7):508-14. PubMed ID: 18397225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deleterious effects of silymarin on the expression of genes controlling endothelial nitric oxide synthase activity in carbon tetrachloride-treated rat livers.
    Cho YK; Yun JW; Park JH; Kim HJ; Park DI; Sohn CI; Jeon WK; Kim BI; Jin W; Kwon YH; Shin MK; Yoo TM; Kang JH; Park CS
    Life Sci; 2009 Aug; 85(7-8):281-90. PubMed ID: 19527736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. N-acetylcysteine prevents carbon tetrachloride-induced liver cirrhosis: role of liver transforming growth factor-beta and oxidative stress.
    Galicia-Moreno M; Rodríguez-Rivera A; Reyes-Gordillo K; Segovia J; Shibayama M; Tsutsumi V; Vergara P; Moreno MG; Muriel P
    Eur J Gastroenterol Hepatol; 2009 Aug; 21(8):908-14. PubMed ID: 19398917
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Taurocholate transport by liver plasma membrane vesicles is not altered in cirrhotic rats.
    Krähenbühl S; Meier-Abt PJ; Reichen J
    J Hepatol; 1989 Jul; 9(1):1-9. PubMed ID: 2549120
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New mechanism in the modulation of carbon tetrachloride hepatotoxicity in rats using different natural antioxidants.
    Al-Rasheed NM; Fadda LM; Ali HM; Abdel Baky NA; El-Orabi NF; Al-Rasheed NM; Yacoub HI
    Toxicol Mech Methods; 2016 May; 26(4):243-50. PubMed ID: 27043868
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Experimental studies on the effect of hepatoprotective compounds.
    Lapis K; Jeney A; Divald A; Vajta G; Zalatnai A; Schaff Z
    Tokai J Exp Clin Med; 1986; 11 Suppl():135-45. PubMed ID: 3330627
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decreased hepatic glycogen content and accelerated response to starvation in rats with carbon tetrachloride-induced cirrhosis.
    Krahenbuhl S; Weber FL; Brass EP
    Hepatology; 1991 Dec; 14(6):1189-95. PubMed ID: 1959869
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The effect of hepatoprotectors on lipid metabolism in CCl4-hepatitis].
    Vengerovskiĭ AI; Chuchalin VS; Paul's OV; Saratikov AS
    Biull Eksp Biol Med; 1987 Apr; 103(4):430-2. PubMed ID: 3567336
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative determination of five metabolites of aspirin by UHPLC-MS/MS coupled with enzymatic reaction and its application to evaluate the effects of aspirin dosage on the metabolic profile.
    Li JP; Guo JM; Shang EX; Zhu ZH; Liu Y; Zhao BC; Zhao J; Tang ZS; Duan JA
    J Pharm Biomed Anal; 2017 May; 138():109-117. PubMed ID: 28192718
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Fat absorption and transportation in patients with liver cirrhosis and in CCl4-induced cirrhotic rats (author's transl)].
    Miura S; Asakura H; Kobayashi K; Munakata Y; Yoshioka M; Morishita T; Tsuchiya M
    Nihon Shokakibyo Gakkai Zasshi; 1982 Feb; 79(2):205-13. PubMed ID: 7098109
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.